Farms.com Home   News

Case IH Executives Appointed to 2022 AEM Board Positions

The Association of Equipment Manufacturers (AEM) has re-elected Scott Harris, Case IH global president, to serve on its board of directors. Kurt Coffey, Case IH vice president of North America, has been appointed to the Ag Sector Board.

AEM officers and directors work on behalf of all member companies, giving their time and talent to provide strategic direction and guidance for association action in areas such as public policy, market data and exhibitions, as well as technical, safety and regulatory issues, and education/training.

AEM is the international trade group based in North America representing off-road equipment manufacturers and suppliers with more than 1,000 companies and more than 200 product lines in the agriculture- and construction-related industry sectors. It is headquartered in Milwaukee, Wisconsin, with offices in Washington, D.C.; Ottawa, Canada; and Beijing, China. CNH Industrial has been a member of AEM since 1894.

Source : Case IH

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.